Biomea Fusion to Participate in Citi's SMID Biotech C-Suite Fireside Chat Series
Biomea Fusion (Nasdaq: BMEA) will participate in Citi's SMID Biotech C-Suite Fireside Chat Series on Thursday, October 23, 2025 at 8:00 a.m. PT / 11:00 a.m. ET. A live audio webcast will be available via the company's Investors & Media site and a replay will be posted after the event. The company is a clinical-stage diabetes and obesity firm and will join the session as scheduled.
Investors can access the live audio webcast and subsequent replay at https://investors.biomeafusion.com/news-events/events.
Biomea Fusion (Nasdaq: BMEA) parteciperà a la Citi's SMID Biotech C-Suite Fireside Chat Series il giovedì 23 ottobre 2025 alle 8:00 a.m. PT / 11:00 a.m. ET. Una trasmissione audio in diretta sarà disponibile tramite il sito degli Investitori e dei Media dell'azienda e una riproduzione sarà pubblicata dopo l'evento. L'azienda è una realtà clinica in fase clinica nel campo del diabete e dell'obesità e parteciperà alla sessione come previsto.
Gli investitori possono accedere alla trasmissione audio in diretta e alla successiva riproduzione su https://investors.biomeafusion.com/news-events/events.
Biomea Fusion (Nasdaq: BMEA) participará en Citi's SMID Biotech C-Suite Fireside Chat Series el jueves 23 de octubre de 2025 a las 8:00 a.m. PT / 11:00 a.m. ET. Una transmisión de audio en vivo estará disponible a través del sitio de Inversores y Medios de la empresa y se publicará una reproducción después del evento. La empresa es una firma clínica en etapas de diabetes y obesidad y se unirá a la sesión según lo programado.
Los inversores pueden acceder a la transmisión de audio en vivo y a la reproducción posterior en https://investors.biomeafusion.com/news-events/events.
Biomea Fusion (나스닥: BMEA)는 Citi의 SMID 생명공학 C-Suite Fireside Chat Series에 2025년 10월 23일 목요일에 오전 8:00 PT / 오전 11:00 ET에 참여할 예정입니다. 라이브 오디오 생중계는 회사의 Investors & Media 사이트를 통해 제공되며 이벤트 후 재방송이 게시됩니다. 이 회사는 임상-stage 당뇨병 및 비만 분야의 기업이며 예정대로 세션에 참여합니다.
투자자들은 라이브 오디오 생중계와 이후 재방송에 https://investors.biomeafusion.com/news-events/events에서 접속할 수 있습니다.
Biomea Fusion (Nasdaq: BMEA) participera à Citi's SMID Biotech C-Suite Fireside Chat Series le jeudi 23 octobre 2025 à 8h00 PT / 11h00 ET. Une diffusion audio en direct sera disponible via le site Investisseurs & Médias de l'entreprise et un rediffusion sera publiée après l'événement. L'entreprise est une société en phase clinique dans les domaines du diabète et de l'obésité et participera à la session comme prévu.
Les investisseurs peuvent accéder à la diffusion audio en direct et à la rediffusion ultérieure sur https://investors.biomeafusion.com/news-events/events.
Biomea Fusion (Nasdaq: BMEA) wird an der Citi's SMID Biotech C-Suite Fireside Chat Series am Donnerstag, 23. Oktober 2025 um 8:00 Uhr PT / 11:00 Uhr ET teilnehmen. Ein Live-Audio-Webcast wird über die Website des Unternehmens für Investoren & Medien verfügbar sein, und eine Wiederholung wird nach der Veranstaltung veröffentlicht. Das Unternehmen ist ein klinisch aktives Diabetes- und Adipositas-Unternehmen und wird wie geplant an der Sitzung teilnehmen.
Investoren können den Live-Audio-Webcast und die nachfolgende Wiederholung unter https://investors.biomeafusion.com/news-events/events aufrufen.
Biomea Fusion (ناسداك: BMEA) ستشارك في سلسلة Citi's SMID Biotech C-Suite Fireside Chat Series يوم الخميس 23 أكتوبر 2025 في الساعة 8:00 صباحاً بتوقيت المحيط الهادئ / 11:00 صباحاً بتوقيت شرق الولايات المتحدة. ستكون هناك بث صوتي مباشر عبر موقع الشركة الخاص بالـ Investors & Media وسيتم نشر إعادة بعد الحدث. الشركة هي شركة في مرحلة سريرية في مجالات السكري والسمنة وستنضم إلى الجلسة كما هو مقرر.
يمكن للمستثمرين الوصول إلى البث الصوتي المباشر وإعادة البث فيما بعد عبر https://investors.biomeafusion.com/news-events/events.
Biomea Fusion (纳斯达克: BMEA) 将参与 Citi 的 SMID 生物科技 C-Suite Fireside Chat Series，时间为 2025 年 10 月 23 日星期四，太平洋时间 8:00 AM / 东部时间 11:00 AM。现场音频网络直播将通过公司投资者与媒体网站提供，事件结束后将提供回放。公司是一家处于临床阶段的糖尿病和肥胖领域公司，将按计划参加该会议。
投资者可以通过 https://investors.biomeafusion.com/news-events/events 访问现场音频网络直播及随后的回放。
- None.
- None.
SAN CARLOS, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announced that it will participate in Citi’s SMID Biotech C-Suite Fireside Chat Series on Thursday, October 23, 2025, at 8:00 a.m. Pacific Time / 11:00 a.m. Eastern Time.
A live audio webcast of the discussion will be available here or by visiting the Investors & Media section of Biomea’s website at https://investors.biomeafusion.com/news-events/events. A replay of the webcast will be available following the live event.
About Biomea Fusion
Biomea Fusion is a clinical-stage diabetes and obesity medicines company focused on the development of its oral small molecule therapies, icovamenib and BMF-650, for diabetes and obesity. These programs target metabolic disorders, a global health challenge affecting nearly half of Americans and one-fifth of the world’s population. Biomea’s mission is to deliver transformative treatments that restore health for patients living with diabetes, obesity, and related conditions. We aim to cure.
Visit us at biomeafusion.com and follow us on LinkedIn, X and Facebook.
Contact:
Meichiel Jennifer Weiss
Sr. Director of Investor Relations and Corporate Development
ir@biomeafusion.com
FAQ
When will Biomea Fusion (BMEA) participate in Citi's SMID Biotech C-Suite Fireside Chat?
How can I listen to the live Biomea Fusion (BMEA) fireside chat on October 23, 2025?
Will a replay of the Biomea Fusion (BMEA) Citi fireside chat be available after the live event?
What topics will Biomea Fusion (BMEA) cover during the Citi SMID Biotech fireside chat?
Is the Biomea Fusion (BMEA) fireside chat audio-only or a video webcast?
